PCM
EW icon

Parsons Capital Management’s Edwards Lifesciences EW Stock Holding History

Parsons Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Hold
3,120
– – 0.01% 462
2026
Q1 		$250K Sell
3,120
-49
-2% -$4.04K 0.01% 443
2025
Q4 		$270K Hold
3,169
– – 0.01% 415
2025
Q3 		$246K Hold
3,169
– – 0.01% 421
2025
Q2 		$248K Hold
3,169
– – 0.02% 404
2025
Q1 		$230K Sell
3,169
-114
-3% -$8.16K 0.01% 406
2024
Q4 		$243K Sell
3,283
-486
-13% -$34K 0.01% 409
2024
Q3 		$249K Hold
3,769
– – 0.02% 403
2024
Q2 		$348K Sell
3,769
-67
-2% -$5.93K 0.02% 353
2024
Q1 		$367K Sell
3,836
-9
-0.2% -$756 0.03% 353
2023
Q4 		$293K Buy
3,845
+12
+0.3% +$835 0.02% 378
2023
Q3 		$266K Buy
3,833
+8
+0.2% +$643 0.02% 375
2023
Q2 		$361K Sell
3,825
-8
-0.2% -$695 0.03% 344
2023
Q1 		$317K Sell
3,833
-115
-3% -$9.04K 0.03% 354
2022
Q4 		$295K Buy
3,948
+16
+0.4% +$1.23K 0.02% 359
2022
Q3 		$325K Buy
3,932
+23
+0.6% +$2.21K 0.03% 336
2022
Q2 		$372K Buy
3,909
+52
+1% +$5.38K 0.03% 324
2022
Q1 		$454K Buy
3,857
+89
+2% +$9.98K 0.03% 318
2021
Q4 		$488K Sell
3,768
-1
-0% -$117 0.04% 315
2021
Q3 		$427K Sell
3,769
-8
-0.2% -$913 0.03% 315
2021
Q2 		$391K Buy
3,777
+2
+0.1% +$189 0.03% 322
2021
Q1 		$316K Buy
3,775
+3
+0.1% +$254 0.03% 338
2020
Q4 		$344K Buy
3,772
+1
+0% +$83 0.03% 302
2020
Q3 		$301K Buy
3,771
+3
+0.1% +$234 0.03% 296
2020
Q2 		$260K Hold
3,768
– – 0.03% 305
2020
Q1 		$237K Sell
3,768
-735
-16% -$53K 0.03% 283
2019
Q4 		$350K Buy
4,503
+597
+15% +$46.6K 0.04% 279
2019
Q3 		$286K Sell
3,906
-234
-6% -$16.4K 0.03% 293
2019
Q2 		$255K Sell
4,140
-3
-0.1% -$181 0.03% 306
2019
Q1 		$264K Buy
+4,143
New +$236K 0.03% 301

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Parsons Capital Management's EW Position: Q2 2026 in Review

Parsons Capital Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 3,120 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #462.

Parsons Capital Management first reported a position in EW in Q1 2019 and has held it in 30 quarters since. The position peaked at $488K in Q4 2021. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Parsons Capital Management held 3,120 shares of Edwards Lifesciences worth $282K as of Q2 2026.
  • Parsons Capital Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Parsons Capital Management's portfolio in Q2 2026, its #462 holding.
  • Parsons Capital Management first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 30 quarters since.
  • Parsons Capital Management's Edwards Lifesciences position peaked at $488K in Q4 2021.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.